35.26

1.84% -0.66

Newamsterdam Pharma Company Nv (NAMS)

Panoramica Notizia Cronologia dei prezzi Financials Perché NAMS Giù? Forum Previsione

Precedente Chiudi:

$35.92

Aprire:

$36.01

Volume 24 ore:

564.23K

Relative Volume:

0.45

Capitalizzazione di mercato:

$4.12B

Reddito:

$22.57M

Utile/perdita netta:

$-212.73M

Rapporto P/E:

-19.54

EPS:

-1.8045

Flusso di cassa netto:

$-142.19M

1 W Prestazione:

+1.23%

1M Prestazione:

+20.22%

6M Prestazione:

+2.59%

1 anno Prestazione:

+60.13%

Intervallo 1D:

$34.15

$36.17

Intervallo di 1 settimana:

$33.81

$37.37

Portata 52W:

$20.53

$42.20

Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile

Nome

Newamsterdam Pharma Company Nv

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

35 206 2971

Indirizzo

GOOIMEER 2-35, NARRDEN

Dipendente

100

Cinguettio

Prossima data di guadagno

2026-08-05

Ultimi documenti SEC

NAMS's Discussions on Twitter

Compare NAMS vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NAMS Newamsterdam Pharma Company Nv	35.26	4.12B	22.57M	-212.73M	-142.19M	-1.8045
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-18	Iniziato	Truist	Buy
2025-10-20	Ripresa	H.C. Wainwright	Buy
2025-08-25	Iniziato	Wells Fargo	Overweight
2025-07-17	Iniziato	Goldman	Neutral
2025-06-17	Iniziato	Citigroup	Buy
2025-06-10	Iniziato	Stifel	Buy
2025-06-04	Iniziato	Cantor Fitzgerald	Overweight
2024-12-30	Iniziato	H.C. Wainwright	Buy
2024-05-15	Iniziato	TD Cowen	Buy
2024-03-14	Iniziato	Scotiabank	Sector Outperform
2024-01-18	Iniziato	Guggenheim	Buy
2024-01-16	Iniziato	Piper Sandler	Overweight
2023-10-30	Iniziato	RBC Capital Mkts	Outperform

Mostra tutto

Newamsterdam Pharma Company Nv Borsa (NAMS) Ultime notizie

04:21 AM

Price to sales forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

04:21 AM

Jul 08, 2026

Responsive Playbooks and the NAMS Inflection - Stock Traders Daily

Jul 08, 2026

Jul 05, 2026

NewAmsterdam Pharma (NAMS) Alzheimer’s Data Push Puts Fair Value Back In Focus - Sahm

Jul 05, 2026

Jul 03, 2026

NAMSNewAmsterdam Pharma Company NV Latest SEC Filings - Finviz

Jul 03, 2026

Jul 02, 2026

(NAMSW) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Jul 02, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jul 02, 2026

NewAmsterdam Pharma awards stock incentives to four new hires - Stock Titan

Jul 02, 2026

Jul 01, 2026

NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026 - marketscreener.com

Jul 01, 2026

NewAmsterdam Pharma Company N.V. - TradingView

Jul 01, 2026

NewAmsterdam Pharma puts obicetrapib in Alzheimer’s spotlight at AAIC 2026 - Stock Titan

Jul 01, 2026

Jun 28, 2026

Price to sales forward of NewAmsterdam Pharma Company N.V. – BOATS:NAMSW - TradingView

Jun 28, 2026

Enterprise value to revenue forward of NewAmsterdam Pharma Company N.V. – BOATS:NAMSW - TradingView

Jun 28, 2026

Enterprise value to revenue forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView

Jun 28, 2026

Enterprise value to EBIT forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView

Jun 28, 2026

Jun 27, 2026

Price to sales forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView

Jun 27, 2026

Price to book forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView

Jun 27, 2026

Understanding the Setup: (NAMS) and Scalable Risk - Stock Traders Daily

Jun 27, 2026

Price to book forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

Jun 27, 2026

Price to book forward of NewAmsterdam Pharma Company N.V. – LSX:A3DUAC - TradingView

Jun 27, 2026

NewAmsterdam Pharma Company N.V. Actuals & Estimates (NASDAQ:NAMS) - TradingView

Jun 27, 2026

NAMS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026

Jun 26, 2026

NewAmsterdam Pharma Company N.V. Actuals & Estimates (MUN:KH6) - TradingView

Jun 26, 2026

Enterprise value to EBITDA forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

Jun 26, 2026

Enterprise value to revenue forward of NewAmsterdam Pharma Company N.V. – LSX:A3DUAC - TradingView

Jun 26, 2026

NewAmsterdam Pharma Company N.V. Actuals & Estimates (LSX:A3DUAC) - TradingView

Jun 26, 2026

Jun 25, 2026

Enterprise value to EBIT forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

Jun 25, 2026

NewAmsterdam Pharma (NAMS) Slides 2.76% as Stock Tests Key Support LevelsRounding Bottom - dars.gov.et

Jun 25, 2026

Price to earnings forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

Jun 25, 2026

Jun 24, 2026

NewAmsterdam Pharma (NAMS) CAO exercises options and sells 40,000 shares - Stock Titan

Jun 24, 2026

Price to earnings forward of NewAmsterdam Pharma Company N.V. – LSX:A3DUAC - TradingView

Jun 24, 2026